Arthritis Treatment Center, Frederick, Maryland Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2011
NCT01374971
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Arthritis Treatment Center, Frederick, Maryland, United States, 21702 | Arthritis Treatment Center, Maryland | Nathan Wei, MD dba Arthritis Treatment Center, Frederick, MD 21702 USA | Nathan Wei, MD, PA d/b/a Arthritis Treatment Center, 301-694-5800

Active Ingredients

Drugs in Phase 4 Trials (1)

corticotropin (acthar) (1 trial)

Drugs in Phase 3 Trials (2)

certolizumab pegol (cimzia) (1 trial)

diclofenac (voltaren) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3